Sowery Richard D, Siemens D Robert
Department of Urology, Kingston General Hospital, Queen's University, Kingston, Ontario, Canada.
Can J Urol. 2004 Oct;11(5):2407-10.
To characterize tumor growth of patients managed conservatively for renal cell carcinoma.
Patients electing conservative management of radiographically determined renal cell carcinomas were referred to a surveillance database. Exclusion criteria consisted of locally advanced disease (>T2) and those with metastatic disease. Clinical follow-up included renal imaging with ultrasound or computed tomography at least every 6 months.
Twenty-two patients were originally managed conservatively, two of whom subsequently underwent nephrectomy because of rapid tumor growth. Mean follow-up was 26 months. Mean tumor volume and diameter at presentation was 62.4 cc and 4.08 cm respectively. Overall tumor growth was 24 cc/year by volume or .86 cm/year diameter.
Given the stage migration of incidentally detected renal masses, the natural history of these tumors remains incomplete. Overall tumor growth in selected populations appear to be slow even in those diagnosed with larger masses. These data may be useful in counseling patients and directing further trials on conservative therapy for renal cell carcinoma.
描述接受肾细胞癌保守治疗患者的肿瘤生长情况。
选择对经影像学检查确诊的肾细胞癌进行保守治疗的患者纳入监测数据库。排除标准包括局部晚期疾病(>T2)和有转移疾病的患者。临床随访包括至少每6个月进行一次肾脏超声或计算机断层扫描成像检查。
最初有22例患者接受保守治疗,其中2例因肿瘤快速生长随后接受了肾切除术。平均随访时间为26个月。初诊时肿瘤平均体积和直径分别为62.4立方厘米和4.08厘米。总体肿瘤体积增长为每年24立方厘米,直径增长为每年0.86厘米。
鉴于偶然发现的肾肿块存在分期迁移,这些肿瘤的自然病程仍不完整。即使在诊断为较大肿块的患者中,特定人群的总体肿瘤生长似乎也很缓慢。这些数据可能有助于为患者提供咨询,并指导进一步的肾细胞癌保守治疗试验。